Endocrine Therapy Drugs Market, by Drug Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

The endocrine system of the human body uses hormones to control and coordinate with the human body's metabolism, reproduction, energy level, growth and development, as well as response for stress, injury, and mood disorders. Endocrine therapy, also known as hormone therapy, adds, blocks, or removes hormones/chemicals in order to treat diseases such as breast cancer, diabetes, etc. Estrogen and progesterone found in a woman's body can aggravate breast cancer as these hormones help the cells grow and spread throughout the body. Two types of endocrine therapy can be used for the treatment of breast cancer, i.e. a) blocking the action of estrogen and progesterone to stop them from helping cancerous cells to grow and, b) using drugs or surgery to stop the ovary from producing estrogen and progesterone. Some of the endocrine therapy drugs used in breast cancer treatment include Abemaciclib (Verzenio), Anastrozole (Arimidex), Exemestane (Aromasin), and Fulvestrant (Faslodex), among others.

Market Dynamics

The increasing prevalence of chronic diseases such as diabetes, breast cancer, and others, rising research and development activities to develop novel endocrine therapy drugs (ETDs), and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global endocrine therapy drugs (ETDs) market over the forecast period.

For instance, according to the International Federation of Diabetes Atlas 2019, around 463 million people aged 20-79 years and 136 million people aged 65 are estimated to be suffering from diabetes in 2019, globally. Moreover, according to the International Diabetes Federation Diabetes Atlas 2019, the prevalence of diabetes in Costa Rica is predicted to increase form 9.1 in 2019 to 10.3 by 2030.

Key features of the study:

This report provides an in-depth analysis of the global endocrine therapy drugs (ETDs) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global endocrine therapy drugs (ETDs) market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Novo Nordisk A/S, AstraZeneca, Generex Biotechnology, Orion Pharma AB, Sanofi, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co.,Inc., Bayer AG, Eli Lilly and Company, Abbott, Tonghua Dongbao Pharmaceutical Co., Ltd., Merck & Co., Inc., TherapeuticsMD, Inc., Pfizer Inc., Allergan, BioSante Pharmaceuticals, Amgen Inc., Noven Pharmaceuticals, Inc., and QuatRx Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global endocrine therapy drugs (ETDs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine therapy drugs (ETDs) market

Detailed Segmentation:

Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type:
- Anti-diabetic Drugs
- Anti-osteoporosis Drugs
- Contraceptive Drugs
- Breast Cancer Drugs
- Others (Menopause Drugs, among others)
Global Endocrine Therapy Drugs (ETDs) Market, By Application:
- Diabetes
- Breast Cancer
- Osteoporosis
- Menopause
- Contraception
- Others (Gender Reassignment Surgery, Hypothyroidism, among others)
Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Endocrine Therapy Drugs (ETDs) Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novo Nordisk A/S*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- AstraZeneca
- Generex Biotechnology
- Orion Pharma AB
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Hoffmann-La Roche
- Hisamitsu Pharmaceutical Co.,Inc.
- Bayer AG
- Eli Lilly and Company
- Abbott
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- TherapeuticsMD, Inc.
- Pfizer Inc.
- Allergan
- BioSante Pharmaceuticals
- Amgen Inc.
- Noven Pharmaceuticals, Inc.
- QuatRx Pharmaceuticals

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5193

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Reimbursement Scenario
Mergers & Acquisitions
Epidemiology

4. Global Endocrine Therapy Drugs (ETDs) Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
Impact on Clinical Trials and Drug Development
Government Initiatives

5. Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Anti-diabetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Anti-osteoporosis Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Contraceptive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Breast Cancer Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others (Menopause Drugs, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Endocrine Therapy Drugs (ETDs) Market, By Application, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Contraception
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others (Gender Reassignment Surgery, Hypothyroidism, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Endocrine Therapy Drugs (ETDs) Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
North America
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Novo Nordisk A/S
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- AstraZeneca
- Generex Biotechnology
- Orion Pharma AB
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche
- Hisamitsu Pharmaceutical Co.,Inc.
- Bayer AG
- Eli Lilly and Company
- Abbott
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- TherapeuticsMD, Inc.
- Pfizer Inc.
- Allergan
- BioSante Pharmaceuticals
- Amgen Inc.
- Noven Pharmaceuticals, Inc.
- QuatRx Pharmaceuticals
Analyst Views

10. Section

References
Research Methodology
About us and Sales Contact

Endocrine Therapy Drugs Market, by Drug Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030